Creative Planning’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Creative Planning’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,400	Closed	-$142K	–	4645
2014 Q4	$142K	Sell	8,400 -662	-7%	-$9.31K	﹤0.01%	1345
2014 Q3	$108K	Buy	9,062 +2,000	+28%	+$13.7K	﹤0.01%	1425
2014 Q2	$40K	Sell	7,062 -6,999	-50%	-$32.2K	﹤0.01%	2034
2014 Q1	$52K	Buy	14,061 +500	+4%	+$1.91K	﹤0.01%	1784
2013 Q4	$46K	Sell	13,561 -22,639	-63%	-$93.5K	﹤0.01%	1665
2013 Q3	$153K	Buy	36,200 +35,650	+6,482%	+$169K	﹤0.01%	885
2013 Q2	$3K	Buy	+550	New	+$1.89K	﹤0.01%	2779

Creative Planning's AVNR Position: Q1 2015 in Review

Creative Planning sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 8,400 shares — an estimated $142K sold.

Creative Planning first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $153K in Q3 2013. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Creative Planning reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Creative Planning sold 8,400 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $142K.
Creative Planning first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Creative Planning's AVANIR PHARMACEUTICALS, INC CL A position peaked at $153K in Q3 2013.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Creative Planning's 13F filing for Q1 2015, filed 13 Apr 2015.